Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 25-Jan-24 4:01 PM View:  | Levi Rami Avraham Director | Pluristem Therapeutics, Inc. (PLUR) | 23-Jan-24 | Grant | 37,100 | -- | -- | 186% 20.0K to 57.1K | |
| 25-Jan-24 4:01 PM View: | Aberman Zami Director | Pluristem Therapeutics, Inc. (PLUR) | 23-Jan-24 | Grant | 44,100 | -- | -- | 3% 1.58M to 1.63M | |
| 25-Jan-24 4:01 PM View: | Abony Lorne Kenneth Director | Pluristem Therapeutics, Inc. (PLUR) | 23-Jan-24 | Grant | 36,750 | -- | -- | 100% 0 to 36.75K | |
| 25-Jan-24 4:01 PM View: | Shemesh-Rasmussen Maital Director | Pluristem Therapeutics, Inc. (PLUR) | 23-Jan-24 | Grant | 38,150 | -- | -- | 191% 20.0K to 58.15K | |
| 25-Jan-24 4:01 PM View: | Franco-Yehuda Chen Chief Financial Officer | Pluristem Therapeutics, Inc. (PLUR) | 23-Jan-24 | Grant | 355,000 | -- | -- | 302% 117.72K to 472.72K | |
| 25-Jan-24 4:01 PM View: | Birger Pinhas Doron Director | Pluristem Therapeutics, Inc. (PLUR) | 23-Jan-24 | Grant | 39,900 | -- | -- | 200% 20.0K to 59.9K | |
| 25-Jan-24 4:01 PM View: | Yanay Yaky Chief Executive Officer Director | Pluristem Therapeutics, Inc. (PLUR) | 23-Jan-24 | Grant | 700,000 | -- | -- | 40% 1.77M to 2.47M | |
| 22-Dec-22 8:56 AM View: | Yanay Yaky Chief Executive Officer Director | Pluristem Therapeutics, Inc. (PLUR) | 22-Dec-22 | Grant | 334,821 | -- | -- | 23% 1.43M to 1.77M | |
| 22-Dec-22 8:52 AM View: | Aberman Zami Director | Pluristem Therapeutics, Inc. (PLUR) | 20-Dec-22 | Sale | 2,000 | $0.97 | $1,940.00 | (< 1%) 1.59M to 1.58M | |
| 14-Feb-22 4:00 PM View: | Aberman Zami Director | Pluristem Therapeutics, Inc. (PLUR) | 10-Feb-22 | Market Purchase | 80,616 | $1.80 | $145,109.00 | 5% 1.51M to 1.59M | 2% |
| 26-Jul-21 4:24 PM View: | Shalev Varda Director | Pluristem Therapeutics, Inc. (PLUR) | 15-Jul-21 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 26-Jul-21 4:23 PM View: | Birger Pinhas Doron Director | Pluristem Therapeutics, Inc. (PLUR) | 15-Jul-21 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 01-Jun-21 7:34 AM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 28-May-21 | Market Sale | 115,007 | $3.72 | $427,826.00 | (4%) 3.24M to 3.12M | 1% |
| 01-Jun-21 7:34 AM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 27-May-21 | Market Sale | 95,885 | $3.69 | $353,816.00 | (3%) 3.33M to 3.24M | < 1% |
| 01-Jun-21 7:34 AM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 26-May-21 | Market Sale | 144,678 | $3.68 | $532,635.00 | (4%) 3.48M to 3.33M | (< 1%) |
| 27-May-21 6:15 AM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 25-May-21 | Market Sale | 261,238 | $3.84 | $1,003,150.00 | (7%) 3.74M to 3.48M | (< 1%) |
| 27-May-21 6:15 AM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 24-May-21 | Market Sale | 79,300 | $3.83 | $303,719.00 | (2%) 3.82M to 3.74M | < 1% |
| 27-May-21 6:15 AM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 21-May-21 | Market Sale | 69,838 | $3.98 | $277,955.00 | (2%) 3.89M to 3.82M | 7% |
| 04-May-21 4:06 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 03-May-21 | Market Sale | 23,721 | $4.28 | $101,526.00 | (< 1%) 3.91M to 3.89M | |
| 04-May-21 4:06 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 30-Apr-21 | Market Sale | 166,004 | $4.66 | $773,579.00 | (4%) 4.08M to 3.91M | |
| 06-Jan-21 4:30 PM View: | Shemesh-Rasmussen Maital Director | Pluristem Therapeutics, Inc. (PLUR) | 05-Jan-21 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 07-Jan-21 4:33 PM View: | Levi Rami Avraham Director | Pluristem Therapeutics, Inc. (PLUR) | 05-Jan-21 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 01-Dec-20 4:10 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 30-Nov-20 | Market Purchase | 20,000 | $9.70 | $194,000.00 | < 1% 4.06M to 4.08M | (25%) |
| 03-Nov-20 4:51 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 30-Oct-20 | Market Purchase | 50,000 | $9.51 | $475,500.00 | 1% 4.01M to 4.06M | (23%) |
| 29-Oct-20 4:27 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 29-Oct-20 | Market Purchase | 20,000 | $9.20 | $184,000.00 | < 1% 3.99M to 4.01M | (20%) |
| 01-Oct-20 4:12 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 30-Sep-20 | Market Purchase | 139,006 | $10.34 | $1,437,320.00 | 4% 3.85M to 3.99M | (30%) |
| 01-Oct-20 4:12 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 29-Sep-20 | Market Purchase | 60,123 | $9.76 | $586,800.00 | 2% 3.79M to 3.85M | (26%) |
| 29-Sep-20 4:05 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 28-Sep-20 | Market Purchase | 13,189 | $9.49 | $125,164.00 | < 1% 3.78M to 3.79M | (23%) |
| 25-Sep-20 4:10 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 24-Sep-20 | Market Purchase | 34,800 | $9.02 | $313,896.00 | < 1% 3.74M to 3.78M | (19%) |
| 24-Sep-20 4:33 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 23-Sep-20 | Market Purchase | 10,734 | $9.04 | $96,983.40 | < 1% 3.73M to 3.74M | (19%) |
| 10-Sep-20 5:10 PM View: | Shorrer Doron Director | Pluristem Therapeutics, Inc. (PLUR) | 10-Sep-20 | Grant | 20,000 | -- | -- | 22% 89.72K to 109.72K | |
| 10-Sep-20 5:12 PM View: | Germain Mark Director | Pluristem Therapeutics, Inc. (PLUR) | 10-Sep-20 | Grant | 20,000 | -- | -- | 32% 62.57K to 82.57K | |
| 10-Sep-20 4:50 PM View: | Franco-Yehuda Chen Chief Financial Officer | Pluristem Therapeutics, Inc. (PLUR) | 10-Sep-20 | Grant | 100,000 | -- | -- | 564% 17.72K to 117.72K | |
| 10-Sep-20 4:46 PM View: | Aberman Zami Executive Chairman Director | Pluristem Therapeutics, Inc. (PLUR) | 10-Sep-20 | Grant | 1,000,000 | -- | -- | 198% 505.11K to 1.51M | |
| 10-Sep-20 5:14 PM View: | Kwiat Moria Director | Pluristem Therapeutics, Inc. (PLUR) | 10-Sep-20 | Grant | 20,000 | -- | -- | 54% 37.36K to 57.36K | |
| 10-Sep-20 4:48 PM View: | Yanay Yaky CEO & President Director | Pluristem Therapeutics, Inc. (PLUR) | 10-Sep-20 | Grant | 1,000,000 | -- | -- | 232% 431.95K to 1.43M | |
| 10-Sep-20 5:08 PM View: | Braun Isaac Director | Pluristem Therapeutics, Inc. (PLUR) | 10-Sep-20 | Grant | 20,000 | -- | -- | 31% 63.62K to 83.62K | |
| 03-Aug-20 6:21 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 31-Jul-20 | Market Purchase | 14,536 | $9.43 | $137,074.00 | < 1% 3.72M to 3.73M | (22%) |
| 03-Aug-20 6:21 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 30-Jul-20 | Market Purchase | 51,235 | $9.19 | $470,850.00 | 1% 3.66M to 3.72M | (20%) |
| 30-Jul-20 7:13 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 29-Jul-20 | Market Purchase | 121,926 | $9.03 | $1,100,990.00 | 3% 3.54M to 3.66M | (20%) |
| 29-Jul-20 4:12 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 28-Jul-20 | Market Purchase | 81,198 | $8.46 | $686,935.00 | 2% 3.46M to 3.54M | (13%) |
| 28-Jul-20 4:13 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 27-Jul-20 | Market Purchase | 49,396 | $8.34 | $411,963.00 | 1% 3.41M to 3.46M | (12%) |
| 07-Jul-20 4:12 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 29-Jun-20 | Market Purchase | 110,897 | $8.41 | $932,644.00 | 3% 3.3M to 3.41M | (12%) |
| 07-Jul-20 4:12 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 24-Jun-20 | Market Purchase | 25,000 | $8.05 | $201,250.00 | < 1% 3.28M to 3.3M | (10%) |
| 07-Jul-20 4:12 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 23-Jun-20 | Market Purchase | 4,789 | $7.67 | $36,731.60 | < 1% 3.27M to 3.28M | (4%) |
| 07-Jul-20 4:12 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 22-Jun-20 | Market Purchase | 59,000 | $7.36 | $434,240.00 | 2% 3.21M to 3.27M | (< 1%) |
| 29-Jun-20 7:23 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 18-Jun-20 | Market Purchase | 49,000 | $7.36 | $360,640.00 | 2% 3.16M to 3.21M | < 1% |
| 29-Jun-20 7:23 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 10-Jun-20 | Market Purchase | 25,000 | $6.91 | $172,750.00 | < 1% 3.14M to 3.16M | 6% |
| 29-Jun-20 7:23 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 09-Jun-20 | Market Purchase | 72,142 | $7.15 | $515,815.00 | 2% 3.07M to 3.14M | 2% |
| 29-Jun-20 7:23 PM View: | Clover Wolf Capital - Limit... 10% Owner | Pluristem Therapeutics, Inc. (PLUR) | 08-Jun-20 | Market Purchase | 178,717 | $7.36 | $1,315,360.00 | 6% 2.89M to 3.07M | (< 1%) |
